Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market
Holding INTS?
Track your performance easily

Intensity Therapeutics, Inc. (INTS) Financial Statements

28 Followers

Intensity Therapeutics, Inc. Financial Overview

Intensity Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-1.099; its P/E ratio is -3.02; Intensity Therapeutics, Inc. is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23
Income Statement-
Total Revenue---
Gross Profit---
EBIT$ -4.97M$ -4.60M$ -3.17M
EBITDA$ -4.96M$ -4.59M$ -3.17M
Net Income Common Stockholders$ -4.97M$ -4.60M$ -3.13M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.34M$ 10.46M$ 14.78M
Total Assets$ 8.67M$ 12.37M$ 17.30M
Total Debt$ 151.00K$ 157.00K$ 158.00K
Net Debt$ -6.19M$ -10.30M$ -14.62M
Total Liabilities$ 3.33M$ 2.69M$ 4.13M
Stockholders Equity$ 5.33M$ 9.74M$ 13.16M
Cash Flow-
Free Cash Flow$ -4.21M$ -4.37M$ -947.17K
Operating Cash Flow$ -4.21M$ -4.37M$ -947.17K
Investing Cash Flow$ -6.00K$ 3.26M$ 2.82M
Financing Cash Flow$ 3.00K$ 8.00K$ -12.16K
Currency in USD

Intensity Therapeutics, Inc. Earnings and Revenue History

Intensity Therapeutics, Inc. Debt to Assets

Intensity Therapeutics, Inc. Cash Flow

Intensity Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis